查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855905

2025年全球In Silico蛋白质设计市场报告

In Silico Protein Design Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，In Silico蛋白质设计市场呈指数级增长，预计从2024年的15.4亿美元增长到2025年的18.7亿美元，复合年增长率高达21.4%。这段历史性成长时期的主要驱动因素包括：人们对蛋白质疗法的认识不断提高、对先进免疫疗法的兴趣日益浓厚、对永续和环境友好型生物技术解决方案的需求不断增长、人们越来越重视透过蛋白质设计来提高药物疗效，以及云端基础技术在研究中的日益普及。

预计未来几年，In Silico辅助蛋白质设计市场将呈指数级增长，到2029年市场规模将达到40.2亿美元，复合年增长率（CAGR）为21.1%。预测期内的成长预计将受到以下因素的推动：机器学习在蛋白质建模领域的应用日益广泛、计算生物学投资不断增加、对经济高效的药物发现方法的需求不断增长、对精准医疗的日益重视以及生物製药需求的不断上升。预测期内的关键趋势包括：人工智慧主导的蛋白质建模技术的进步、量子运算的整合、自动化蛋白质设计平台的开发、从头蛋白质合成技术的创新以及多组体学资料整合技术的进步。

In Silico辅助蛋白质设计是指利用电脑建模和模拟技术，而非实验室实验，来创建或修改蛋白质结构的过程。计算工具用于预测胺基酸序列的折迭和相互作用方式，从而设计出具有特定形状和功能的蛋白质。这种方法能够加速蛋白质发现，降低成本，并使研究人员能够在实验检验之前探索多种可能性。

用于In Silico蛋白质设计的软体主要分为云端基础软体和本地部署软体。云端基础软体是指运行在互联网上的数位平台，用户无需在本机上安装或维护即可存取高级蛋白质设计应用程式。这些工具融合了分子建模、人工智慧、机器学习演算法和同源建模等技术。应用领域包括药物发现与开发、酵素工程、生物标记发现、疫苗学和学术研究。最终用户包括製药和生物技术公司以及学术研究机构。

美国在2025年春季突然提高关税及其引发的贸易摩擦对製药公司造成了严重衝击。利润丰厚的学名药生产商尤其脆弱，一些公司不得不缩减低利润药物的生产规模。生物技术公司也因关税导致的专用试剂短缺而面临临床试验延期。为因应这一局面，製药业正在印度和欧洲扩大原料药的生产，增加库存，并游说政府对基本药物给予贸易豁免。

本In Silico报告是商业研究公司（The Business Research Company）最新系列报告的一部分，该系列报告提供电脑辅助蛋白质设计市场统计数据，例如全球电脑辅助蛋白质设计行业的市场规模、区域份额、市场In Silico排名、详细In Silico市场细分、市场趋势和商业机会，以及在In Silico蛋白质设计行业取得成功所需的数据。这份In Silico辅助In Silico设计市场研究报告对该行业的现状和未来发展趋势进行了详细分析，为您提供所需的一切观点。

未来几年，对个人化医疗日益增长的需求预计将推动In Silico蛋白质设计市场的发展。个人化医疗是指根据个人的基因谱、生活方式和环境因素来制定个人化的治疗和预防策略。基因组技术的进步以及以价值为导向的医疗模式的日益普及，推动了这项需求的成长。这些模式旨在改善患者预后并降低整体医疗成本。In Silico蛋白质设计能够快速创建针对特定患者需求的治疗性蛋白质，从而为个人化医疗提供支援。例如，个人化医疗联盟（PMC）在2024年2月报告称，美国食品药物管理局（FDA）在2023年核准了16种针对罕见疾病患者的新型个人化疗法。这种对个人化医疗需求的激增正在推动In Silico蛋白质设计市场的成长。

In Silico蛋白质设计市场中的公司正在开发先进的解决方案，例如一键式蛋白质设计平台，以加速药物发现、提高治疗效果并促进新型生技药品的研发。一键式蛋白质设计平台是一种自动化工具，使研究人员能够以最少的人工干预快速设计和修饰蛋白质。例如，总部位于英国的生物技术公司 Latent Labs 于 2025 年 7 月推出了 Latent-X，这是一种生成式人工智慧模型，使用户无需编程专业知识即可上传标靶并在原子水平上设计大环化合物和微型结合剂。该平台对大环化合物和粘合剂的命中率很高，实现了皮摩尔到微摩尔级的结合亲和性，并具有实验室检验的特异性。该系统产生完整蛋白质序列和结构的速度也远超传统方法，标誌着蛋白质治疗领域的重大飞跃，并加速了该领域的创新。

2023年7月，德国生技公司BioNTech SE收购了InstaDeep Ltd.，以增强其人工智慧能力。此次收购将BioNTech在免疫疗法和疫苗研发方面的专长与InstaDeep先进的人工智慧和机器学习技术相结合，从而强化人工智慧驱动的药物发现和开发。伙伴关係旨在促进创新治疗方法的研发，尤其是在癌症和感染疾病领域。总部位于英国的InstaDeep Ltd.In Silico蛋白质设计技术而闻名，此次收购可望加速前沿治疗药物的研发。

In Silico辅助蛋白质设计市场由提供蛋白质结构建模、蛋白质工程与最佳化、抗体和生物设计、分子对接以及虚拟筛检等服务的营业单位所获得的收入所构成。市场价值包括服务供应商销售的或包含在其服务产品中的相关产品的价值。该市场还包括优化蛋白质、酵素变体、胜肽、候选疫苗、蛋白质模型和研究试剂套件的销售。该市场的价值为“出厂价”，即产品製造商或创建者向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场的产品价值还包括产品创建者提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球In Silico蛋白质设计：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球In Silico蛋白质设计市场：成长率分析
  • 全球In Silico蛋白质设计市场表现：规模与成长，2019-2024年
  • 全球In Silico蛋白质设计市场预测：规模与成长，2024-2029年，2034年预测
  • 全球In Silico蛋白质设计：潜在市场规模 (TAM)

第六章 市场细分

  • 全球In Silico蛋白质设计市场：依软体类型、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 云端基础的软体
  • 本地部署软体
  • 全球In Silico蛋白质设计市场：依技术类型、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 分子建模
  • 人工智慧和机器学习演算法
  • 同源建模
  • 其他技术类型
  • 全球In Silico蛋白质设计市场：按应用、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 药物发现与开发
  • 酵素工程
  • 生物标记发现
  • 疫苗学
  • 学术研究
  • 全球In Silico蛋白质设计市场：依最终使用者、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 製药和生物技术公司
  • 学术研究机构
  • 其他最终用户
  • 全球In Silico蛋白质设计市场：云端基础软体、类型、实际值及预测值细分，2019-2024年、2024-2029年预测值、2034年预测值
  • 订阅制
  • 按次付费
  • 混合云端
  • 全球In Silico蛋白质设计市场：依本地部署软体、类型、效能和预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 企业许可证
  • 永久许可
  • 客製化解决方案

第七章 区域和国家分析

  • 全球In Silico蛋白质设计市场：依地区、绩效及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 全球In Silico蛋白质设计市场：按国家、绩效和预测，2019-2024 年、2024-2029 年预测、2034 年预测

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • In Silico蛋白质设计市场：竞争格局
  • In Silico辅助蛋白质设计市场：公司简介
    • Dassault Systemes SE Overview, Products and Services, Strategy and Financial Analysis
    • Schrodinger Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Generate Biomedicines Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Insilico Medicine Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Chemical Computing Group ULC Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Arzeda Corp.
  • Outpace Bio Inc.
  • Evozyne Inc.
  • Cradle Bio BV
  • Seismic Therapeutics Inc.
  • Profluent Bio Inc.
  • Nabla Bio Inc.
  • Antiverse Ltd.
  • EvolutionaryScale Inc.
  • RevolKa Ltd.
  • Molecular Discovery Ltd.
  • Inte：Ligand GmbH
  • Kuano Ltd.
  • AI Proteins Inc.
  • Menten AI Inc.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年In Silico蛋白质设计市场：提供新机会的国家
  • 2029年In Silico蛋白质设计市场：新兴细分市场机会
  • 2029年In Silico蛋白质设计市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38554

In silico protein design is the process of creating or modifying protein structures using computer-based modeling and simulations rather than laboratory experiments. It employs computational tools to predict how amino acid sequences will fold and interact, enabling the design of proteins with specific shapes and functions. This approach accelerates discovery, reduces costs, and allows researchers to explore numerous possibilities before experimental validation.

The primary software types for in silico protein design include cloud-based software and on-premise software. Cloud-based software refers to digital platforms that operate over the internet, providing access to advanced protein design applications without requiring installation or maintenance on local computers. These tools incorporate technologies such as molecular modeling, artificial intelligence and machine learning algorithms, homology modeling, and others. Applications include drug discovery and development, enzyme engineering, biomarker discovery, vaccinology, and academic research. End users include pharmaceutical and biotechnology companies, academic and research institutions, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The in silico protein design market research report is one of a series of new reports from The Business Research Company that provides in silico protein design market statistics, including in silico protein design industry global market size, regional shares, competitors with a in silico protein design market share, detailed in silico protein design market segments, market trends and opportunities, and any further data you may need to thrive in the in silico protein design industry. This in silico protein design market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in silico protein design market size has grown exponentially in recent years. It will grow from $1.54 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 21.4%. Growth in the historic period was driven by rising awareness of protein therapeutics, growing interest in advanced immunotherapies, increasing demand for sustainable and eco-friendly biotechnology solutions, stronger focus on enhancing drug efficacy through protein design, and greater use of cloud-based technologies in research.

The in silico protein design market size is expected to see exponential growth in the next few years. It will grow to $4.02 billion in 2029 at a compound annual growth rate (CAGR) of 21.1%. Growth in the forecast period is expected to result from expanding applications of machine learning in protein modeling, increased investment in computational biology, greater demand for cost-effective drug discovery approaches, rising emphasis on precision medicine, and growing demand for biopharmaceuticals. Key trends anticipated for the forecast period include advancements in AI-driven protein modeling, integration of quantum computing, development of automated protein design platforms, innovation in de novo protein synthesis, and progress in multi-omics data integration.

The growing demand for personalized medicine is expected to drive the growth of the in silico protein design market in the coming years. Personalized medicine tailors medical treatments and prevention strategies to an individual's genetic profile, lifestyle, and environmental factors. This demand is increasing due to advancements in genomic technologies and the growing adoption of value-based care models, which focus on improving patient outcomes while reducing overall healthcare costs. In silico protein design supports personalized medicine by enabling the rapid creation of customized therapeutic proteins that are tailored to specific patient needs. For example, in February 2024, the Personalized Medicine Coalition (PMC) reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, a significant rise from six approvals in 2022. This surge in demand for personalized medicine is fueling the growth of the in silico protein design market.

Companies in the in silico protein design market are developing advanced solutions, such as push-button protein design platforms, to speed up drug discovery, enhance therapeutic efficacy, and facilitate the creation of novel biologics. Push-button protein design platforms are automated tools that allow researchers to quickly design and modify proteins with minimal manual intervention. For instance, in July 2025, UK-based biotechnology company Latent Labs launched Latent-X, a generative AI model that enables users with no coding expertise to upload targets and design macrocycles and mini-binders at the atomic level. This platform delivers high hit rates for macrocycles and mini-binders and achieves picomolar to micromolar binding affinities with lab-verified specificity. The system also produces complete protein sequences and structures much faster than previous methods, making it a significant leap forward in protein therapeutics and accelerating innovation in the field.

In July 2023, BioNTech SE, a German biotechnology company, acquired InstaDeep Ltd. to strengthen its AI capabilities. This acquisition combines BioNTech's expertise in immunotherapy and vaccine development with InstaDeep's advanced artificial intelligence and machine learning technologies, enhancing AI-powered drug discovery and development. The partnership aims to improve the creation of innovative therapies, particularly in cancer and infectious diseases. InstaDeep Ltd., a UK-based company, is known for its in silico protein design technologies, and this acquisition is expected to accelerate the development of cutting-edge therapeutics.

Major players in the in silico protein design market are Dassault Systemes SE, Schrodinger Inc., Generate Biomedicines Inc., Insilico Medicine Inc., Chemical Computing Group ULC, Arzeda Corp., Outpace Bio Inc., Evozyne Inc., Cradle Bio B.V., Seismic Therapeutics Inc., Profluent Bio Inc., Nabla Bio Inc., Antiverse Ltd., EvolutionaryScale Inc., RevolKa Ltd., Molecular Discovery Ltd., Inte:Ligand GmbH, Kuano Ltd., AI Proteins Inc., and Menten AI Inc.

North America was the largest region in the in silico protein design market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in in silico protein design report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the in silico protein design market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in silico protein design market consists of revenues earned by entities by providing services such as protein structure modelling, protein engineering and optimization, antibody and biologic design, molecular docking, and virtual screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The in silico protein design market also includes sales of optimized proteins, enzyme variants, peptides and vaccine candidates, protein models, and research kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Silico Protein Design Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in silico protein design market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in silico protein design ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in silico protein design market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Software Type: Cloud-Based Software; On-Premise Software
  • 2) By Technology Type: Molecular Modelling; Artificial Intelligence And Machine Learning Algorithms; Homology Modelling; Other Technology Types
  • 3) By Application: Drug Discovery And Development; Enzyme Engineering; Biomarker Discovery; Vaccinology; Academic Research
  • 4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Cloud-Based Software: Subscription-Based; Pay-Per-Use; Hybrid Cloud
  • 2) By On-Premise Software: Enterprise License; Perpetual License; Customized Solutions
  • Companies Mentioned: Dassault Systemes SE; Schrodinger Inc.; Generate Biomedicines Inc.; Insilico Medicine Inc.; Chemical Computing Group ULC; Arzeda Corp.; Outpace Bio Inc.; Evozyne Inc.; Cradle Bio B.V.; Seismic Therapeutics Inc.; Profluent Bio Inc.; Nabla Bio Inc.; Antiverse Ltd.; EvolutionaryScale Inc.; RevolKa Ltd.; Molecular Discovery Ltd.; Inte:Ligand GmbH; Kuano Ltd.; AI Proteins Inc.; Menten AI Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In Silico Protein Design Market Characteristics

3. In Silico Protein Design Market Trends And Strategies

4. In Silico Protein Design Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global In Silico Protein Design Growth Analysis And Strategic Analysis Framework

  • 5.1. Global In Silico Protein Design PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global In Silico Protein Design Market Growth Rate Analysis
  • 5.4. Global In Silico Protein Design Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global In Silico Protein Design Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global In Silico Protein Design Total Addressable Market (TAM)

6. In Silico Protein Design Market Segmentation

  • 6.1. Global In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cloud-Based Software
  • On-Premise Software
  • 6.2. Global In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Modelling
  • Artificial Intelligence And Machine Learning Algorithms
  • Homology Modelling
  • Other Technology Types
  • 6.3. Global In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery And Development
  • Enzyme Engineering
  • Biomarker Discovery
  • Vaccinology
  • Academic Research
  • 6.4. Global In Silico Protein Design Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Academic And Research Institutes
  • Other End-Users
  • 6.5. Global In Silico Protein Design Market, Sub-Segmentation Of Cloud-Based Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Subscription-Based
  • Pay-Per-Use
  • Hybrid Cloud
  • 6.6. Global In Silico Protein Design Market, Sub-Segmentation Of On-Premise Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enterprise License
  • Perpetual License
  • Customized Solutions

7. In Silico Protein Design Market Regional And Country Analysis

  • 7.1. Global In Silico Protein Design Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global In Silico Protein Design Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In Silico Protein Design Market

  • 8.1. Asia-Pacific In Silico Protein Design Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In Silico Protein Design Market

  • 9.1. China In Silico Protein Design Market Overview
  • 9.2. China In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In Silico Protein Design Market

  • 10.1. India In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In Silico Protein Design Market

  • 11.1. Japan In Silico Protein Design Market Overview
  • 11.2. Japan In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In Silico Protein Design Market

  • 12.1. Australia In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In Silico Protein Design Market

  • 13.1. Indonesia In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In Silico Protein Design Market

  • 14.1. South Korea In Silico Protein Design Market Overview
  • 14.2. South Korea In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In Silico Protein Design Market

  • 15.1. Western Europe In Silico Protein Design Market Overview
  • 15.2. Western Europe In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In Silico Protein Design Market

  • 16.1. UK In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In Silico Protein Design Market

  • 17.1. Germany In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In Silico Protein Design Market

  • 18.1. France In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In Silico Protein Design Market

  • 19.1. Italy In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In Silico Protein Design Market

  • 20.1. Spain In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In Silico Protein Design Market

  • 21.1. Eastern Europe In Silico Protein Design Market Overview
  • 21.2. Eastern Europe In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In Silico Protein Design Market

  • 22.1. Russia In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In Silico Protein Design Market

  • 23.1. North America In Silico Protein Design Market Overview
  • 23.2. North America In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In Silico Protein Design Market

  • 24.1. USA In Silico Protein Design Market Overview
  • 24.2. USA In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In Silico Protein Design Market

  • 25.1. Canada In Silico Protein Design Market Overview
  • 25.2. Canada In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In Silico Protein Design Market

  • 26.1. South America In Silico Protein Design Market Overview
  • 26.2. South America In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In Silico Protein Design Market

  • 27.1. Brazil In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In Silico Protein Design Market

  • 28.1. Middle East In Silico Protein Design Market Overview
  • 28.2. Middle East In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In Silico Protein Design Market

  • 29.1. Africa In Silico Protein Design Market Overview
  • 29.2. Africa In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In Silico Protein Design Market Competitive Landscape And Company Profiles

  • 30.1. In Silico Protein Design Market Competitive Landscape
  • 30.2. In Silico Protein Design Market Company Profiles
    • 30.2.1. Dassault Systemes SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Schrodinger Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Generate Biomedicines Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Insilico Medicine Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Chemical Computing Group ULC Overview, Products and Services, Strategy and Financial Analysis

31. In Silico Protein Design Market Other Major And Innovative Companies

  • 31.1. Arzeda Corp.
  • 31.2. Outpace Bio Inc.
  • 31.3. Evozyne Inc.
  • 31.4. Cradle Bio B.V.
  • 31.5. Seismic Therapeutics Inc.
  • 31.6. Profluent Bio Inc.
  • 31.7. Nabla Bio Inc.
  • 31.8. Antiverse Ltd.
  • 31.9. EvolutionaryScale Inc.
  • 31.10. RevolKa Ltd.
  • 31.11. Molecular Discovery Ltd.
  • 31.12. Inte:Ligand GmbH
  • 31.13. Kuano Ltd.
  • 31.14. AI Proteins Inc.
  • 31.15. Menten AI Inc.

32. Global In Silico Protein Design Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In Silico Protein Design Market

34. Recent Developments In The In Silico Protein Design Market

35. In Silico Protein Design Market High Potential Countries, Segments and Strategies

  • 35.1 In Silico Protein Design Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 In Silico Protein Design Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 In Silico Protein Design Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer